HERON THERAPEUTICS, INC. /DE/ Sales Revenue, Goods, Net (Deprecated 2018-01-31)
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $10.05 million for the 3-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-02-27
- HERON THERAPEUTICS, INC. /DE/ sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $10.05M, a 686.00% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $8.57M.
- HERON THERAPEUTICS, INC. /DE/ sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $8.51M.
- HERON THERAPEUTICS, INC. /DE/ sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $3.63M.
- HERON THERAPEUTICS, INC. /DE/ sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $30.77M, a 2305.55% increase from fiscal 2016.
- HERON THERAPEUTICS, INC. /DE/ sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $1.28M.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $10.05M 10-K · filed 2018-02-27 | $18.63M derived: sum of 2 quarters · filed 2018-02-27 | $27.14M derived: sum of 3 quarters · filed 2018-02-27 | $30.77M 10-K · filed 2018-02-27 |
| 2017-09-30 | $8.57M 10-K · filed 2018-02-27 | $17.08M derived: sum of 2 quarters · filed 2018-02-27 | $20.71M 10-Q · filed 2017-11-06 | $21.99M derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-06-30 | $8.51M 10-K · filed 2018-02-27 | $12.14M 10-Q · filed 2017-08-09 | $13.42M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2017-03-31 | $3.63M 10-K · filed 2018-02-27 | $4.91M derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2016-12-31 | $1.28M 10-K · filed 2018-02-27 | $1.28M 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |